OAFP + OPS 2025 Conference

Due to a myriad of legal and social reasons, Oregon has one of the lowest rates of sickle cell trait and disease in the nation, yet our patients living with these inherited red blood cell conditions deserve the highest quality of care we can provide. Sickle cell trait was once thought of as a benign trait but we now know it carries health and social risks. Sickle cell disease, after decades of minimal progress, has seen significant medical progress, including gene therapy. However, social progress is slower in coming.